Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee

Jason D. Goldman; Stephanie M. Pouch; Ann E. Woolley; Sarah E. Booker; Courtney Jett; Cole Fox; Gerald J. Berry; Kelly E. Dunn; Chak‐Sum Ho; M. Kittleson; Dong Heun Lee; Deborah J. Levine; Charles C. Marboe; Gary F. Marklin; Raymund R. Razonable; Sarah Taimur; Helen S. Te; Judith A. Anesi; Cynthia E. Fisher; Marty T. Sellers; Anil J. Trindade; Robert Wood; Lorenzo Zaffiri; Marilyn E. Levi; David K. Klassen; Marian G. Michaels; Ricardo M. La Hoz; Lara Danziger‐Isakov

doi:10.1111/tid.14013

Abstract

This is the authors' abstract. We don't add key points for this paper.

Transplantation of SARS-CoV-2 NAT+ donor organs appears safe for short-term outcomes of death and graft loss and ameliorates the organ shortage. Further study is required to assure comparable longer term outcomes.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Goldman et al. (2023) studied this question.

synapsesocial.com/papers/69df47336324afb55d5922ac https://doi.org/10.1111/tid.14013

View at Publisher

Ask AI

Bookmark

Share

Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee

Abstract

Ask about this paper

Discussion

Cite This Study

Transplant of organs from donors with positive SARS‐CoV‐2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading